ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 82 filers reported holding ANI PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,093,000 | -45.2% | 150,000 | -40.0% | 9.74% | -62.9% |
| Q3 2016 | $16,588,000 | -24.8% | 250,000 | -36.7% | 26.27% | -1.7% |
| Q2 2016 | $22,049,000 | +65.8% | 395,000 | 0.0% | 26.73% | +36.9% |
| Q1 2016 | $13,296,000 | -14.6% | 395,000 | +14.5% | 19.53% | -24.2% |
| Q4 2015 | $15,568,000 | +15.9% | 345,000 | +1.5% | 25.75% | +34.4% |
| Q3 2015 | $13,434,000 | +73.2% | 340,000 | +172.0% | 19.16% | +135.2% |
| Q2 2015 | $7,756,000 | -21.6% | 125,000 | -64.3% | 8.15% | -14.7% |
| Q3 2014 | $9,898,000 | +44.4% | 350,000 | +75.9% | 9.55% | +66.2% |
| Q2 2014 | $6,854,000 | +63.7% | 199,000 | +49.0% | 5.75% | +109.9% |
| Q1 2014 | $4,187,000 | -57.0% | 133,558 | -72.5% | 2.74% | -61.7% |
| Q4 2013 | $9,747,000 | +80.1% | 485,410 | -12.4% | 7.15% | +51.1% |
| Q3 2013 | $5,413,000 | – | 554,088 | – | 4.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |